Magnesium and health: between biological plausibility and clinical evidence

Initial note for the reader
This article was previously published and has been updated according to scientific and divulgative criteria. It is for informational purposes only and does not replace professional medical advice. For personal evaluations, always consult a doctor or a qualified healthcare professional.

In brief

• Magnesium is an essential mineral involved in numerous cellular processes; its deficiency is associated with various cardiometabolic risk indicators.
• Observational evidence links higher magnesium intake to a lower risk of stroke, diabetes, and, in part, cardiovascular diseases.
• Evidence from clinical trials suggests modest effects on blood pressure and metabolic parameters; results are heterogeneous and depend on dose, duration, and the studied population.
• Diets rich in fruits, vegetables, legumes, nuts, and whole grains improve magnesium intake and overall diet quality; the use of supplements should be evaluated on a case-by-case basis.

Abstract: what does science say?

Magnesium is a biologically active mineral with well-documented roles in numerous enzymatic reactions, muscle function, and the regulation of vascular tone. Population studies show inverse associations between dietary magnesium intake and the risk of stroke, diabetes, and sometimes cardiovascular disease, while meta-analyses of clinical trials indicate modest but consistent effects on blood pressure and insulin sensitivity in specific groups. Experiments on indicators of endothelial function are conflicting: some studies in patients with coronary artery disease reported improvements, but trials in healthy or overweight populations often do not document significant benefits. The overall evidence supports the biological plausibility and population-level benefits of adequate dietary intake, while the generalized utility of pharmacological supplementation remains limited and dependent on the clinical context, baseline magnesium status, and the dose/duration of administration. It is important to distinguish between observational associations and definitive causal evidence.

Main section — Biological mechanisms and physiological framework

Biological role of magnesium

Magnesium is a divalent cation fundamental for cellular biochemistry: it acts as a cofactor for hundreds of enzymes that control energy production (ATP), protein synthesis, nucleotide stability, and signal transduction. This role explains why alterations in magnesium status can affect cardiovascular and metabolic functions. The reference literature collects arcs of molecular and physiological evidence on the role of magnesium in muscle contractility, vascular tone regulation, and glucose metabolism. [2]

Acidity, pH, and limitations of the "acidic terrain" hypothesis

Blood pH is strictly regulated by buffer systems, ventilation, and renal function; diet mainly modifies the renal acid load and urinary pH, not blood pH in healthy subjects. Dietary strategies that increase fruits and vegetables reduce the so-called potential renal acid production and alter urine pH, but the evidence does not support simplistic conclusions that directly link a slight variation in acid-base balance to the onset of cardiovascular diseases. [1]

Epidemiological and clinical evidence

Observational data: associations with cardiovascular risk and stroke

Cohort studies and meta-analyses suggest that higher dietary magnesium intake is associated with a lower risk of cardiometabolic events. A meta-analysis of cohorts highlighted a reduction in stroke risk with increases in dietary magnesium, while analyses on multiple outcomes (CVD, diabetes, mortality) confirm inverse but not definitive associations for causality. These results support the plausibility of a protective effect at the population level, while acknowledging the possible role of confounding factors related to lifestyle and overall diet quality. [3][4]

Evidence from clinical trials: blood pressure, endothelial function, and inflammation

Meta-analyses of randomized trials report modest reductions in blood pressure with magnesium supplementation, particularly at higher doses and in hypertensive or uncontrolled subjects. However, RCTs on endothelial function show conflicting results: some trials in patients with coronary artery disease showed improvements in flow-mediated dilation, while trials in non-diseased or overweight populations often found no significant effects. For inflammatory markers (e.g., CRP), recent meta-analyses show heterogeneous results: some studies suggest limited reductions in specific subgroups, others find no robust effects. These differences depend on participant characteristics, duration, form of magnesium, and dosage. [5][6][7][8]

Practical section — What it means in practice

The gathered evidence indicates that improving dietary magnesium intake is a reasonable strategy within the framework of a quality diet (more vegetables, legumes, nuts, seeds, and whole grains). For the general population, this approach supports numerous aspects of health and reduces the risk of deficiencies. Supplementation with magnesium preparations can be useful in selected contexts—for example, in the presence of documented hypomagnesemia, in some clinical conditions, or in therapies that promote losses (diuretics, some oncological drugs)—but it is not a universal solution or a "panacea." Decisions on supplementation, form, and dose should be based on clinical evaluation, laboratory tests, and dialogue with the doctor: the individual risk profile (renal insufficiency, concomitant therapies) can influence safety and efficacy. [2][9]

Forms of magnesium and practical questions

Various forms exist (oxide, citrate, gluconate, aspartate, glycinate) with different bioavailability and intestinal tolerability. The choice of form can influence the degree of absorption and gastrointestinal side effects. There is no "one-size-fits-all dose": trials and dose-response analyses indicate that clinical effects are more likely with moderate-to-high doses and treatments lasting weeks or months, but safety and tolerability vary. Communicating with your doctor before starting supplements is essential, especially in the presence of kidney disease or concomitant therapies. [5][13]

Key points to remember

• Magnesium is essential and participates in many fundamental biological reactions; maintaining adequate dietary intake is advisable.
• Observational evidence links magnesium intake to lower risks of stroke and some metabolic conditions; causal evidence is less consolidated.
• Clinical trials show modest effects on blood pressure and insulin sensitivity in specific contexts; not all studies agree.
• Supplementation may be indicated on a clinical basis but is not recommended as a universal remedy without medical evaluation.

Limitations of the evidence

It is important to distinguish between observational studies and causal evidence. Cohorts show associations useful for hypotheses but can be influenced by confounding factors (e.g., overall diet quality, physical activity, medication use). Clinical trials, while offering greater control, present heterogeneity in dose, form of magnesium, duration, and population: some are small, short-term, or conducted in people without initial deficiency, which limits the observability of an effect. Furthermore, measuring magnesium status is complex: serum magnesium represents only a fraction of the total body magnesium and may not reflect intracellular status. Therefore, the results require careful and contextual interpretation. [2][7][8][13]

Editorial conclusion

Magnesium has a solid biological basis that makes its role in cardiometabolic health plausible. Epidemiological and experimental evidence supports the importance of adequate dietary intake. However, the narrative that presents magnesium supplementation as a "panacea for all ills" is not consistent with current data: documented clinical benefits are in many cases modest and depend on the context, baseline status, and type of intervention. The reasonable practical recommendation is to promote diets rich in foods that are natural sources of magnesium and to reserve supplementation for clinically motivated situations, evaluated by a doctor. Research remains active, and larger, better-characterized trials will be needed to define populations, doses, and administration methods that can translate into certain clinical improvements.

Editorial note

The article has been updated to adhere to criteria of clarity, transparency, and scientific rigor. The information reported here is for divulgative purposes and does not replace medical consultation. For therapeutic decisions, consult a healthcare professional.

SCIENTIFIC RESEARCH

List of cited sources (in order of appearance). All references include verifiable DOIs.

1. Remer T, Manz F. Diet-induced acidosis: is it real and clinically relevant? Br J Nutr. 2010;103(8):1185-1194. https://doi.org/10.1017/S0007114509993047
2. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in Man: Implications for Health and Disease. Physiol Rev. 2015;95(1):1-46. https://doi.org/10.1152/physrev.00012.2014
3. Fang X, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies. BMC Med. 2016;14:210. https://doi.org/10.1186/s12916-016-0742-z
4. Larsson SC, et al. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr. 2012;95(2):362-366. https://doi.org/10.3945/ajcn.111.022376
5. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66:411-418. https://doi.org/10.1038/ejcn.2012.4
6. Shechter M, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102(19):2353-2358. https://doi.org/10.1161/01.CIR.102.19.2353
7. van Mil AC, et al. Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: a randomized controlled trial. Scientific Reports. 2017;7: (article) https://doi.org/10.1038/s41598-017-00205-9
8. Talebi S, et al. The Effect of Oral Magnesium Supplementation on Inflammatory Biomarkers in Adults: A Comprehensive Systematic Review and Dose-response Meta-analysis of Randomized Clinical Trials. Biol Trace Elem Res. 2021. https://doi.org/10.1007/s12011-021-02783-2
9. Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016;111:272-282. https://doi.org/10.1016/j.phrs.2016.06.019